QuadraMed Names Sandra Trakowski Vice President, Clinical Product Management
23 Abril 2007 - 7:54AM
Business Wire
QuadraMed� Corporation (Amex:QD) today announced that Sandra
Trakowski, MS, RN, BC, has been appointed Vice President, Clinical
Product Management. Her responsibilities include strategic planning
for and management of QuadraMed�s Care Management product suite.
These applications provide a total solution to help healthcare
organizations maximize clinician decision support for significantly
improved patient safety and more efficient delivery of quality
care. Ms. Trakowski joins QuadraMed from Care Fusion, Inc., McLean,
Virginia, where she served more than three years as vice president
of clinical products. Her other experience includes five years as
associate director of nursing informatics at Washington Hospital
Center in Washington, DC, and positions with TDS Healthcare
Systems, the predecessor of Eclipsys, and the National Institutes
of Health. Sandy Trakowski earned her Bachelor of Science degree in
Nursing from George Mason University, and was awarded a Master of
Sport Science, Sports Medicine from the United States Sports
Academy. For information about all QuadraMed Care-Based Revenue
Cycle� solutions and related services, visit www.quadramed.com or
call 800.393.0278. About QuadraMed Corporation QuadraMed
Corporation advances the success of healthcare organizations
through IT solutions that leverage quality care into positive
financial outcomes. Using QuadraMed�s Care-Based Revenue Cycle
solutions, which are designed to optimize the patient experience
and leverage quality of care into payment, our clients seek to
receive the proper reimbursement, in the shortest time, at the
lowest administrative cost. QuadraMed delivers real world solutions
that help healthcare professionals deliver outstanding patient care
with significant efficiency. Behind our products and services is a
staff of 600 professionals whose experience and dedication to
service have earned QuadraMed the trust and loyalty of customers at
approximately 2,000 healthcare provider facilities. Cautionary
Statement on Risks Associated with QuadraMed�s Forward-Looking
Statements This press release contains forward-looking statements,
as defined in Section 27A of the Securities Act of 1933 and Section
21E of the Securities Exchange Act of 1934, by QuadraMed that are
subject to risks and uncertainties. The words "believe," "expect,"
"anticipate," "intend," "plan," "estimate," "may," "should,"
"could," and similar expressions are intended to identify such
statements. Forward-looking statements are not guarantees of future
performance and are to be interpreted only as of the date on which
they are made. QuadraMed undertakes no obligation to update or
revise any forward-looking statement except as required by law.
QuadraMed advises investors that it discusses risk factors and
uncertainties that could cause QuadraMed�s actual results to differ
from forward-looking statements in its periodic reports filed with
the Securities and Exchange Commission ("SEC"). QuadraMed�s SEC
filings can be accessed through the Investor Relations section of
our website, www.quadramed.com, or through the SEC�s EDGAR Database
at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833). QuadraMed
is a registered trademark of QuadraMed Corporation. All other
trademarks are the property of their respective holders.
Quadramed (AMEX:QD)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Quadramed (AMEX:QD)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024
Real-Time news about Quadramed Corp. (American Stock Exchange): 0 recent articles
Más de QuadraMed Corporation ArtÃculos de Noticias